
Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”
We don’t believe we did anything wrong and it doesn’t matter much anyway ...
continue reading...
Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”
We don’t believe we did anything wrong and it doesn’t matter much anyway ...
continue reading...
Over 1,100 Benicar lawsuits are pending in a New Jersey multidistrict litigation, according to recent court estimates. Plaintiffs who have filed Benicar lawsuits claim that Japanese ...
continue reading...
Benicar, Daiichi Sankyo’s brand-name olmesartan, was approved in 2002 by the U.S. Food and Drug ...
continue reading...
The litigation, overseen by District Judge Michael Schneider in the U.S. District Court for the District of New Jersey, already includes over 1,100 Benicar lawsuits. These have been filed by patients who claim Daiichi Sankyo’s hypertension drug Benicar caused ...
continue reading...
Benicar was approved by the U.S. Food and Drug Administration (FDA) in 2002 for use as a blood pressure medication. ...
continue reading...